ENDRA Life Sciences Common Stock (NDRA) Q3 2025 Earnings

14AugConfirmed
Q3 2024
Q4 2024
Q2 2025
Q3 2025
-140
-93.9
-47.81
-1.71

Details

Expected EPS
-2.27
Actual EPS
-1.71
Surprise EPS
0.56
Surprise Percent
+24.67%

Description

ENDRA Life Sciences Common Stock (NDRA) has reported earnings of -1.71 per share for Q3 2025.

0 Comments

Share your thoughts